FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4310639940> ?p ?o ?g. }

• W4310639940 endingPage "54" @default.
• W4310639940 startingPage "54" @default.
• W4310639940 abstract "Importance Although 1 in 4 head and neck cancer (HNC) survivors experience clinically significant body image distress (BID), a psychosocial morbidity that adversely affects quality of life, effective interventions for these patients are lacking. Objective To evaluate the acceptability and preliminary efficacy of BRIGHT (Building a Renewed ImaGe after Head and neck cancer Treatment), a brief tele–cognitive behavioral therapy, at reducing BID among HNC survivors. Design, Setting, and Participants This parallel-group pilot randomized clinical trial recruited adult HNC survivors with BID between August 13, 2020, and December 9, 2021, from the Medical University of South Carolina HNC clinic during a routine survivorship encounter. Data were analyzed from May 3 to June 16, 2022. Interventions BRIGHT consisted of 5 weekly psychologist-led video tele–cognitive behavioral therapy sessions. Attention control (AC) consisted of dose- and delivery-matched survivorship education. Main Outcomes and Measures Change in HNC-related BID was assessed using IMAGE-HN (Inventory to Measure and Assess imaGe disturbancE–Head and Neck), a validated patient-reported outcome (score range, 0-84, with higher scores indicating greater HNC-related BID). Clinical response rate was measured as the proportion of patients with a clinically meaningful change in IMAGE-HN scores. Results Of the 44 HNC survivors with BID allocated to BRIGHT (n = 20) or AC (n = 24), the median (range) age was 63 (41-80) years, and 27 patients (61%) were female. Patients rated BRIGHT’s acceptability highly (all metrics had a mean rating of ≥4.5/5), and 19 of 20 patients (95%) receiving BRIGHT were likely or highly likely to recommend it to other HNC survivors with BID. BRIGHT decreased HNC-related BID from baseline to 1 month postintervention relative to AC (mean model-based difference in change in IMAGE-HN score, –7.9 points; 90% CI, –15.9 to 0.0 points) and from baseline to 3 months postintervention relative to AC (mean model-based difference in change in IMAGE-HN score, –17.1 points; 90% CI, −25.6 to −8.6 points). At 3 months postintervention, the clinical response rate of BRIGHT was 6.6-fold higher than AC (model-based odds ratio, 6.6; 90% CI, 2.0-21.8). The improvement in HNC-related BID for BRIGHT vs AC at 3 months was clinically significant, and the effect size was large (Cohen d , −0.9; 90% CI, −1.4 to −0.4). Conclusions and Relevance In this pilot randomized clinical trial, BRIGHT was acceptable, may result in a clinically meaningful improvement in HNC-related BID, and showed a high clinical response rate. These promising preliminary data support conducting a large efficacy trial to establish BRIGHT as the first evidence-based treatment for HNC survivors with BID. Trial Registration ClinicalTrials.gov Identifier: NCT03831100" @default.
• W4310639940 created "2022-12-13" @default.
• W4310639940 creator A5000917466 @default.
• W4310639940 creator A5014068004 @default.
• W4310639940 creator A5018903983 @default.
• W4310639940 creator A5021488941 @default.
• W4310639940 creator A5024005208 @default.
• W4310639940 creator A5028552302 @default.
• W4310639940 creator A5029905445 @default.
• W4310639940 creator A5053984557 @default.
• W4310639940 creator A5059217291 @default.
• W4310639940 creator A5084264697 @default.
• W4310639940 creator A5091543376 @default.
• W4310639940 date "2023-01-01" @default.
• W4310639940 modified "2023-10-18" @default.
• W4310639940 title "Efficacy of a Brief Tele–Cognitive Behavioral Treatment vs Attention Control for Head and Neck Cancer Survivors With Body Image Distress" @default.
• W4310639940 cites W1610409501 @default.
• W4310639940 cites W1766812542 @default.
• W4310639940 cites W1902159119 @default.
• W4310639940 cites W1905402320 @default.
• W4310639940 cites W1930612960 @default.
• W4310639940 cites W1969365817 @default.
• W4310639940 cites W1977733462 @default.
• W4310639940 cites W1978232609 @default.
• W4310639940 cites W2001582105 @default.
• W4310639940 cites W2053351876 @default.
• W4310639940 cites W2055788278 @default.
• W4310639940 cites W2066192341 @default.
• W4310639940 cites W2086733802 @default.
• W4310639940 cites W2098648448 @default.
• W4310639940 cites W2123481594 @default.
• W4310639940 cites W2124938803 @default.
• W4310639940 cites W2126939865 @default.
• W4310639940 cites W2145555293 @default.
• W4310639940 cites W2153177161 @default.
• W4310639940 cites W2154162649 @default.
• W4310639940 cites W2305033403 @default.
• W4310639940 cites W2534656414 @default.
• W4310639940 cites W2556159786 @default.
• W4310639940 cites W2620250573 @default.
• W4310639940 cites W2801879001 @default.
• W4310639940 cites W2884440658 @default.
• W4310639940 cites W2897168016 @default.
• W4310639940 cites W2912560737 @default.
• W4310639940 cites W2918272982 @default.
• W4310639940 cites W2937326640 @default.
• W4310639940 cites W2972784372 @default.
• W4310639940 cites W2999505987 @default.
• W4310639940 cites W2999777753 @default.
• W4310639940 cites W3019366189 @default.
• W4310639940 cites W3023051232 @default.
• W4310639940 cites W3029108343 @default.
• W4310639940 cites W3083014995 @default.
• W4310639940 cites W3138739975 @default.
• W4310639940 cites W3162993738 @default.
• W4310639940 cites W3177899902 @default.
• W4310639940 cites W4200470750 @default.
• W4310639940 cites W4235732921 @default.
• W4310639940 cites W4240455823 @default.
• W4310639940 cites W4242673880 @default.
• W4310639940 cites W4243404149 @default.
• W4310639940 cites W4243965192 @default.
• W4310639940 doi "https://doi.org/10.1001/jamaoto.2022.3700" @default.
• W4310639940 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36454561" @default.
• W4310639940 hasPublicationYear "2023" @default.
• W4310639940 type Work @default.
• W4310639940 citedByCount "6" @default.
• W4310639940 countsByYear W43106399402023 @default.
• W4310639940 crossrefType "journal-article" @default.
• W4310639940 hasAuthorship W4310639940A5000917466 @default.
• W4310639940 hasAuthorship W4310639940A5014068004 @default.
• W4310639940 hasAuthorship W4310639940A5018903983 @default.
• W4310639940 hasAuthorship W4310639940A5021488941 @default.
• W4310639940 hasAuthorship W4310639940A5024005208 @default.
• W4310639940 hasAuthorship W4310639940A5028552302 @default.
• W4310639940 hasAuthorship W4310639940A5029905445 @default.
• W4310639940 hasAuthorship W4310639940A5053984557 @default.
• W4310639940 hasAuthorship W4310639940A5059217291 @default.
• W4310639940 hasAuthorship W4310639940A5084264697 @default.
• W4310639940 hasAuthorship W4310639940A5091543376 @default.
• W4310639940 hasConcept C118552586 @default.
• W4310639940 hasConcept C121608353 @default.
• W4310639940 hasConcept C126322002 @default.
• W4310639940 hasConcept C139265228 @default.
• W4310639940 hasConcept C150966472 @default.
• W4310639940 hasConcept C159110408 @default.
• W4310639940 hasConcept C168563851 @default.
• W4310639940 hasConcept C172400760 @default.
• W4310639940 hasConcept C1862650 @default.
• W4310639940 hasConcept C27415008 @default.
• W4310639940 hasConcept C2776530083 @default.
• W4310639940 hasConcept C2779951463 @default.
• W4310639940 hasConcept C535046627 @default.
• W4310639940 hasConcept C70410870 @default.
• W4310639940 hasConcept C71924100 @default.
• W4310639940 hasConceptScore W4310639940C118552586 @default.
• W4310639940 hasConceptScore W4310639940C121608353 @default.
• W4310639940 hasConceptScore W4310639940C126322002 @default.

• next